Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Biorestorative Therapies, Inc. (BRTX : NSDQ)
 
 • Company Description   
BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols, primarily involving adult stem cells. The company's core programs consist of Disc/Spine Program and Metabolic Program. Disc/Spine Program consists of cell therapy candidate, brtxDISC(TM) is a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow. Metabolic Program consists of ThermoStem(R), developing an allogeneic cell-based therapy to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. BioRestorative Therapies, Inc. is based in Melville, New York.

Number of Employees: 14

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.29 Daily Weekly Monthly
20 Day Moving Average: 275,964 shares
Shares Outstanding: 25.48 (millions)
Market Capitalization: $7.39 (millions)
Beta: 0.73
52 Week High: $1.89
52 Week Low: $0.16
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -21.54% -22.15%
12 Week 24.30% 21.25%
Year To Date -75.32% -77.21%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
40 MARCUS DRIVE SUITE 1
-
MELVILLE,NY 11747
USA		 ph: 631-760-8100
fax: -		 ir@biorestorative.com http://www.biorestorative.com
 
 • General Corporate Information   
Officers
Lance Alstodt - Chief Executive Officer; President and Chairman
Robert E. Kristal - Chief Financial Officer
Francisco Silva - Vice President; Research and Development and Direc
Nickolay Kukekov - Director
Patrick F. Williams - Director

Peer Information
Biorestorative Therapies, Inc. (CORR.)
Biorestorative Therapies, Inc. (RSPI)
Biorestorative Therapies, Inc. (CGXP)
Biorestorative Therapies, Inc. (BGEN)
Biorestorative Therapies, Inc. (GTBP)
Biorestorative Therapies, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 090655606
SIC: 8090
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 08/11/26
Share - Related Items
Shares Outstanding: 25.48
Most Recent Split Date: 10.00 (0.00:1)
Beta: 0.73
Market Capitalization: $7.39 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.13 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.66 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/11/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 2.44
Price/Cash Flow: -
Price / Sales: 20.64
EPS Growth
vs. Year Ago Period: 66.07%
vs. Previous Quarter: 48.65%
Sales Growth
vs. Year Ago Period: -8.00%
vs. Previous Quarter: 15.00%
ROE
06/30/26 - -
03/31/26 - -508.42
12/31/25 - -430.91
ROA
06/30/26 - -
03/31/26 - -230.94
12/31/25 - -203.61
Current Ratio
06/30/26 - -
03/31/26 - 2.35
12/31/25 - 0.84
Quick Ratio
06/30/26 - -
03/31/26 - 2.35
12/31/25 - 0.84
Operating Margin
06/30/26 - -
03/31/26 - -3,689.94
12/31/25 - -4,039.17
Net Margin
06/30/26 - -
03/31/26 - -3,088.27
12/31/25 - -3,956.11
Pre-Tax Margin
06/30/26 - -
03/31/26 - -3,088.27
12/31/25 - -3,956.11
Book Value
06/30/26 - -
03/31/26 - 0.12
12/31/25 - 0.04
Inventory Turnover
06/30/26 - -
03/31/26 - -
12/31/25 - -
Debt-to-Equity
06/30/26 - -
03/31/26 - 0.00
12/31/25 - 0.00
Debt-to-Capital
06/30/26 - -
03/31/26 - 0.00
12/31/25 - 0.00
 

Powered by Zacks Investment Research ©